TargED Biopharmaceuticals: Funding, Investors & Team (Sep 2026)
TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
TargED Biopharmaceuticals has raised $44.2M across 1 funding round on record, the most recent a Series A of $44.2M announced in Feb 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
TargED Biopharmaceuticals Company Profile and Key Stats
Latest funding round on record: Feb 2022.
TargED Biopharmaceuticals Funding Rounds
TargED Biopharmaceuticals Founders and Leadership Team
Contact details for the TargED Biopharmaceuticals team: 1 of 1 has an email address on file.
Start 14-day free trial →TargED Biopharmaceuticals Funding Compared to Other Biotechnology Startups
TargED Biopharmaceuticals' latest round of $44.2M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like TargED Biopharmaceuticals in Biotechnology and Utrecht
Companies Similar to TargED Biopharmaceuticals
The Protein Brewery is a high-tech company that specializes in developing and making animal-free- based…
Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral…
Onward is creating an Implantable Neuro-stimulation System (INS) that includes real-time motion feedback and…
Scinvivo is a medical technology company. Scinvivo is involved in bladder cancer medical needs. They provide…
Revyve produces animal-free food ingredients from microorganisms. The company's premium ingredients include…
Merus is dedicated to creating superior treatments for cancer patients and potentially finding a cure. Our…
Salvia BioElectronics is dedicated to creating new neuromodulation devices to help treat migraines. They are…
We are a clinical-stage pharmaceutical company discovering and developing therapies targeting mitochondrial…
QurieGen is a biotechnology company that speeds up the process of finding and creating new drugs.
Protix Biosystems is a biometrics company that offers a range of products which enable its customers to…
QDI Systems is a startup company that engages in the development of advanced imaging devices for medical…
BIMINI Biotech, a startup established in 2019 in Leiden, The Netherlands, focuses on creating groundbreaking…
TargED Biopharmaceuticals Funding FAQs
What does TargED Biopharmaceuticals do?
TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
How much funding has TargED Biopharmaceuticals raised?
TargED Biopharmaceuticals has raised $44.2M across 1 round on record. The most recent is a Series A of $44.2M announced in Feb 2022.
When did TargED Biopharmaceuticals last raise funding?
TargED Biopharmaceuticals' most recent funding round on record is a Series A of $44.2M, announced in Feb 2022.
Who is the CEO of TargED Biopharmaceuticals?
Kristof Vercruysse is listed as CEO at TargED Biopharmaceuticals.
Where is TargED Biopharmaceuticals headquartered?
TargED Biopharmaceuticals is based in Utrecht, Netherlands.
How many employees does TargED Biopharmaceuticals have?
TargED Biopharmaceuticals is in the 1-10 employee band.
How does TargED Biopharmaceuticals' funding compare to other Biotechnology startups?
TargED Biopharmaceuticals' latest round of $44.2M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's TargED Biopharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for TargED Biopharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.